NS
Nitesh Shirishchandra Nanavati
About Nitesh Shirishchandra Nanavati
Data last updated:
Nitesh Shirishchandra Nanavati is a Director at Ethric Pharma Private Limited (since 2014) and Director at Squarithm Advisory Private Limited (since 2026). The companies operate in Trading. The largest current company by reported revenue is Ethric Pharma Private Limited at ₹75,818 (FY 2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ethric Pharma Private Limited U24230GJ2014PTC080903 | Director | 25 Sep 2014 | 2014 | ₹75,818 (FY 2017) | Active |
| Squarithm Advisory Private Limited U70200GJ2026PTC181982 | Director | 07 Aug 2026 | 2026 | Active |
Board colleagues of Nitesh Shirishchandra Nanavati
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mahesh Kishanbhai Moteevaras | 05303669 | Ethric Pharma Private Limited , Squarithm Advisory Private Limited | Director |
| Paresh Chimanlal Chudasama | 06949877 | Ethric Pharma Private Limited | Director |
| Prakashkumar Jentilal Jethva | 09013972 | Squarithm Advisory Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nitesh Shirishchandra Nanavati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nitesh Shirishchandra Nanavati
Nitesh Shirishchandra Nanavati currently holds 2 directorships: Ethric Pharma Private Limited (Director, since 25 Sep 2014, revenue ₹75,818 (FY 2017)); Squarithm Advisory Private Limited (Director, since 07 Aug 2026).
Nitesh Shirishchandra Nanavati was first appointed on 25 Sep 2014 as Director at Ethric Pharma Private Limited. The most recent appointment on record is 07 Aug 2026 at Squarithm Advisory Private Limited.
The current boards of Nitesh Shirishchandra Nanavati's companies include Mahesh Kishanbhai Moteevaras (Ethric Pharma Private Limited), Paresh Chimanlal Chudasama (Ethric Pharma Private Limited), Prakashkumar Jentilal Jethva (Squarithm Advisory Private Limited).